Kiora Pharmaceuticals Inc (KPRX) Short-Term Forecasts And Estimates
Kiora Pharmaceuticals Inc (NASDAQ:KPRX) has a beta value of -0.68 and has seen 22.85 million shares traded in the recent trading session. The company, currently
Kiora Pharmaceuticals Inc (NASDAQ:KPRX) has a beta value of -0.68 and has seen 22.85 million shares traded in the recent trading session. The company, currently
Life360 Inc (NASDAQ:LIF) has a beta value of 4.04 and has seen 1.07 million shares traded in the recent trading session. The company, currently valued
Volato Group Inc (AMEX:SOAR) has a beta value of 0.97 and has seen 21.53 million shares traded in the recent trading session. The company, currently
Carvana Co (NYSE:CVNA) has a beta value of 3.65 and has seen 1.35 million shares traded in the recent trading session. The company, currently valued
Novagold Resources Inc (AMEX:NG) has a beta value of 0.63 and has seen 1.84 million shares traded in the recent trading session. The company, currently
Hanesbrands Inc (NYSE:HBI) has a beta value of 1.51 and has seen 0.98 million shares traded in the recent trading session. The company, currently valued
Abbott Laboratories (NYSE:ABT) has a beta value of 0.74 and has seen 1.27 million shares traded in the recent trading session. The company, currently valued
Accenture plc (NYSE:ACN) has a beta value of 1.33 and has seen 1.04 million shares traded in the recent trading session. The company, currently valued
Canadian Natural Resources Ltd (NYSE:CNQ) has a beta value of 1.06 and has seen 1.75 million shares traded in the recent trading session. The company,
Beyond Meat Inc (NASDAQ:BYND) has a beta value of 2.15 and has seen 1.09 million shares traded in the recent trading session. The company, currently
© 2024, Powered by Smart TechOne